Vaccine development: Process could be fast-tracked using antibody imaging tool

A new imaging approach monitors antibody responses to vaccines more quickly than current techniques, which could accelerate vaccine design 19 January 2022 By Carissa Wong An artist’s illustration of antibodies (red and blue) responding to an infection with SARS-CoV-2 (purple) SCIENCE PHOTO LIBRARY By analysing high-resolution images, a computer can quickly predict the sequence of … Read more

A Common Virus Can Trigger Multiple Sclerosis, According to Huge New Study

Multiple sclerosis – an autoimmune disease that affects the brain and spinal cord – may emerge after infection with Epstein-Barr virus (EBV). An estimated 90 to 95 percent of people catch EBV, also called human herpesvirus 4, by the time they reach adulthood, according to the clinical resource UpToDate.   In children, the virus typically causes an asymptomatic or … Read more

Covid-19 news: Moderna booster stimulates antibodies against omicron

By Michael Le Page, Clare Wilson, Jessica Hamzelou, Sam Wong, Graham Lawton, Adam Vaughan, Conrad Quilty-Harper, Jason Arunn Murugesu and Layal Liverpool A Swiss soldier closes the curtain of a booth prior to the administration of a Moderna covid-19 booster jab in Switzerland. FABRICE COFFRINI/AFP via Getty Images Latest coronavirus news as of 1pm on … Read more

How Well Does Pfizer Protect From Omicron? New Preliminary Results Give Us an Idea

Two doses of Pfizer’s COVID-19 vaccine shot offered about 70 percent protection against hospitalization during a recent surge in Omicron cases in South Africa, preliminary real-world data found.   This was a drop from about 92 percent in a previous Delta wave, the researchers from Discovery Health, South Africa’s largest insurer and South Africa’s Medical Research Council, said … Read more